ADIM
ALE

Alpha DNA Investment Management’s Allete ALE Stock Holding History

Alpha DNA Investment Management’s Portfolio ALE Stock Details ALE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-57
Closed -$3K – 121
2021
Q1 		$3K Buy
+57
New +$3.73K ﹤0.01% 445

Other funds holding ALE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha DNA Investment Management's ALE Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Allete (ALE) in Q2 2021, closing a stake of 57 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in ALE in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 251 funds tracked by Wall St. Rank hold ALE as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Allete position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 57 Allete shares in Q2 2021, an estimated $3K.
  • Alpha DNA Investment Management first reported a position in Allete in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Allete position peaked at $3K in Q1 2021.
  • 251 funds tracked by Wall St. Rank held Allete as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.